Mitochondrial oxidative stress promotes atrial fibrillation

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Xie, Wenjun ^a   Santulli, Gaetano ^a   Reiken, Steven R ^a   Yuan, Qi ^a   Osborne, Brent W ^a   Chen, Bi Xing ^a   Marks, Andrew R ^a,b  

^a Department of Physiology and Cellular Biophysics Wu Center for Molecular Cardiology   (United States)

^b Department of Medicine College of Physi and Surg Columbia University Medical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; REACTIVE OXYGEN METABOLITE; RYANODINE RECEPTOR; S-107 COMPOUND; THIAZEPINE DERIVATIVE;

AGE; ANIMAL; ATRIAL FIBRILLATION; CARDIAC MUSCLE CELL; DISEASE MODEL; DISEASE PREDISPOSITION; DRUG EFFECTS; GENETICS; HEART ATRIUM; HEART MITOCHONDRION; HUMAN; METABOLISM; MOUSE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

AGE FACTORS; ANIMALS; ATRIAL FIBRILLATION; CALCIUM; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; HEART ATRIA; HUMANS; MICE; MICE, TRANSGENIC; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; THIAZEPINES;

EID: 84937046867     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11427     Document Type: Article

References (52)

1. Santulli, G., Iaccarino, G., De Luca, N., Trimarco, B. , Condorelli, G. Atrial fibrillation and microRNAs. Front Physiol 5, 15 (2014).
2. Deedwania, P. C. , Lardizabal, J. A. Atrial fibrillation in heart failure: a comprehensive review. Am J Med 123, 198-204 (2010).
3. Ganesan, A. N., et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc 2, e004549 (2013).
4. D'Ascia, S. L. et al. Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated cardiomyopathy. Int J Clin Pract 65, 1149-1155 (2011).
5. Anderson, E. J. et al. Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillation. J Am Heart Assoc 3, e000713 (2014).
6. Santulli, G., D'Ascia, S. L. , D'Ascia, C. Development of atrial fibrillation in recipients of cardiac resynchronization therapy: the role of atrial reverse remodelling. Can J Cardiol 28, e17 (2012).
7. Aldhoon, B., Melenovsky, V., Peichl, P. , Kautzner, J. New insights into mechanisms of atrial fibrillation. Physiol Res 59, 1-12 (2010).
8. Sovari, A. A. , Dudley, S. C., Jr. Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation. Front Physiol 3, 311 (2012).
9. Santulli, G. , D'Ascia, C. Atrial remodelling in echocardiographic super-responders to cardiac resynchronization therapy. Heart 98, 517 (2012).
10. Pizzale, S., Gollob, M. H., Gow, R. , Birnie, D. H. Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 19, 1319-1321 (2008).
11. Di Pino, A., Caruso, E., Costanzo, L. , Guccione, P. A novel RyR2 mutation in a 2-year-old baby presenting with atrial fibrillation, atrial flutter, and atrial ectopic tachycardia. Heart Rhythm 11, 1480-1483 (2014).
12. Lehnart, S. E. et al. Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J Clin Invest 118, 2230-2245 (2008).
13. Lehnart, S. E. et al. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 109, 3208-3214 (2004).
14. Santulli, G. , Marks, A. R. Essential roles of intracellular calcium release channels in muscle, brain, metabolism, and aging. Curr Mol Pharmacol, in press (2015).
15. Vest, J. A. et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 111, 2025-2032 (2005).
16. Neef, S. et al. CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation. Circ Res 106, 1134-1144 (2010).
17. Shan, J. et al. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia. Circ Res 111, 708-717 (2012).
18. Xie, W. et al. Imaging atrial arrhythmic intracellular calcium in intact heart. J Mol Cell Cardiol 64, 120-123 (2013).
19. Zhang, Y. et al. Acute atrial arrhythmogenicity and altered Ca(2+ ) homeostasis in murine RyR2-P2328S hearts. Cardiovasc Res 89, 794-804 (2011).
20. Korantzopoulos, P., Kolettis, T. M., Galaris, D. , Goudevenos, J. A. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 115, 135-143 (2007).
21. Huang, C. X., Liu, Y., Xia, W. F., Tang, Y. H. , Huang, H. Oxidative stress: a possible pathogenesis of atrial fibrillation. Med Hypotheses 72, 466-467 (2009).
22. Mihm, M. J. et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104, 174-180 (2001).
23. Carnes, C. A. et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 89, E32-38 (2001).
24. Sakabe, M. et al. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction. J Cardiovasc Electrophysiol 23, 1130-1135 (2012).
25. Dai, D. F. , Rabinovitch, P. S. Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc Med 19, 213-220 (2009).
26. Santulli, G. , Iaccarino, G. Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes. Immun Ageing 10, 10 (2013).
27. Shan, J. et al. Role of chronic ryanodine receptor phosphorylation in heart failure and beta-adrenergic receptor blockade in mice. J Clin Invest 120, 4375-4387 (2010).
28. Cooper, L. L. et al. Redox modification of ryanodine receptors by mitochondria-derived reactive oxygen species contributes to aberrant Ca2+ handling in ageing rabbit hearts. J Physiol 591, 5895-5911 (2013).
29. Jiang, X. et al. Polydatin protects cardiac function against burn injury by inhibiting sarcoplasmic reticulum Ca2+ leak by reducing oxidative modification of ryanodine receptors. Free Radic Biol Med 60, 292-299 (2013).
30. Yano, M. et al. Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure. Circulation 112, 3633-3643 (2005).
31. Yuan, Q. et al. Functional Role of Calstabin2 in Age-related Cardiac Alterations. Sci Rep 4, 7425 (2014).
32. Marx, S. O. , Marks, A. R. Dysfunctional ryanodine receptors in the heart: New insights into complex cardiovascular diseases. J Mol Cell Cardiol 58, 225-231 (2013).
33. Chen, B. et al. In situ confocal imaging in intact heart reveals stress-induced Ca(2+ ) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation. Circ Arrhythm Electrophysiol 5, 841-849 (2012).
34. Greiser, M. et al. Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. J Clin Invest 124, 4759-4772 (2014).
35. Santulli, G. et al. CaMK4 Gene Deletion Induces Hypertension. J Am Heart Assoc 1, e001081 (2012).
36. Starkov, A. A. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann N Y Acad Sci 1147, 37-52 (2008).
37. Kowaltowski, A. J., de Souza-Pinto, N. C., Castilho, R. F. , Vercesi, A. E. Mitochondria and reactive oxygen species. Free Radic Biol Med 47, 333-343 (2009).
38. Neuman, R. B. et al. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 53, 1652-1657 (2007).
39. Bukowska, A. et al. Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia. Exp Biol Med (Maywood) 233, 558-574 (2008).
40. Purohit, A. et al. Oxidized Ca(2+ )/calmodulin-dependent protein kinase II triggers atrial fibrillation. Circulation 128, 1748-1757 (2013).
41. Wolke, C., Bukowska, A., Goette, A. , Lendeckel, U. Redox control of cardiac remodeling in atrial fibrillation. Biochim Biophys Acta, 1850(8): 1555-1565 (2015).
42. Reilly, S. N. et al. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 124, 1107-1117 (2011).
43. Lendeckel, U. et al. Expression of opioid receptor subtypes and their ligands in fibrillating human atria. Pacing Clin Electrophysiol 28 Suppl 1, S275-279 (2005).
44. Kohlhaas, M. , Maack, C. Adverse bioenergetic consequences of Na+-Ca2+ exchanger-mediated Ca2+ influx in cardiac myocytes. Circulation 122, 2273-2280 (2010).
45. Santulli, G. et al. Calcium release channel RyR2 regulates insulin release and glucose homeostasis. J Clin Invest, 125(5): 1968-78 (2015).
46. Harbauer, A. B., Zahedi, R. P., Sickmann, A., Pfanner, N. , Meisinger, C. The Protein Import Machinery of Mitochondria-A Regulatory Hub in Metabolism, Stress, and Disease. Cell Metab 19, 357-372 (2014).
47. Tocchetti, C. G. et al. GSH or palmitate preserves mitochondrial energetic/redox balance, preventing mechanical dysfunction in metabolically challenged myocytes/hearts from type 2 diabetic mice. Diabetes 61, 3094-3105 (2012).
48. Schriner, S. E. et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308, 1909-1911 (2005).
49. Umanskaya, A. et al. Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging. Proc Nati Acad Sci USA 111, 15250-15255 (2014).
50. Cheng, H. et al. Amplitude distribution of calcium sparks in confocal images: theory and studies with an automatic detection method. Biophys J 76, 606-617 (1999).
51. Xie, W., Brochet, D. X., Wei, S., Wang, X. , Cheng, H. Deciphering ryanodine receptor array operation in cardiac myocytes. J Gen Physiol 136, 129-133 (2010).
52. Santulli, G. et al. A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. J Clin Invest 124, 4102-4114 (2014).